3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
20
Prostatic Neoplasms
11
Neoplasm Metastasis
9
Melanoma
8
Lung Neoplasms
8
Carcinoma, Renal Cell
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
8
Kidney Neoplasms
7
Sarcoma
6
Liver Neoplasms
6
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Small Cell Lung Carcinoma
3
Osteosarcoma
3
Desmoid Tumors
3
Carcinoma, Ductal, Breast
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Pain
2
Keratosis, Actinic
2
Esophageal Neoplasms
2
Disease
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Wilms Tumor
1
Uveal Melanoma
1
Interventions
lenvatinib
3
Gemcitabine
3
tislelizumab
2
durvalumab
2
Cisplatin
2
toripalimab
1
titanium silicide
1
theasinensin A
1
surufatinib
1
sitravatinib
1
sintilimab
1
regorafenib
1
pembrolizumab
1
S 1 (combination)
1
Nivolumab
1
Folfox protocol
1
Fluorouracil
1
Cryosurgery
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Biliary Tract Cancer
×
Cryosurgery
×
Clear all
NCT05781074
2023-03-24
CASTLE-08
Fudan University
Phase 2
Unknown
25 enrolled